Antibiotic "Klabaks": instructions for use
The drug "Klabaks" instructions for use characterizes as an antibiotic of semi-synthetic origin, which is a macrolide of the last generation. At the heart of this drug is the suppression of protein synthesis directly in the pathogenic cell due to interaction with the ribosomal subunit of the microbe. Use the antibiotic "Klabaks" instructions for use advises to provide the body with a pronounced antibacterial, bacteriostatic and bactericidal effect. The main analogues of this drug, which have a similar effect, are today such drugs as "Krixan", "Binoklar", "Claritrosin", "Claricite", "Arvitsin" and "Fromilid."
The antibiotic "Klabaks" is produced in the form of granules intended for the preparation of suspension, and in the form of tablets. All listed forms contain clarithromycin as an active ingredient. The composition of the granules additionally includes such substances as sodium croscarmellose, microcrystalline cellulose, hydroxypropylcellulose, hypromellose and alginic acid. Tablets contain povidone, water, MCC, magnesium stearate, talc, silicon dioxide, stearic acid and croscarmellose sodium.
The application instruction for "Klabaks" is recommended for use mainly for the elimination of various bacterial infections caused by microorganisms sensitive to clarithromycin. For example, for the treatment of atypical pneumonia, chronic bronchitis, tonsillitis, sinusitis, laryngitis, pharyngitis and other inflammatory diseases of the lower or upper respiratory tract. When impetigo, folliculitis, furunculosis, wound infections and otitis media, you should also start taking the antibiotic "Klabaks".Indications for use include and diseases such as chlamydia, mycobacteriosis( including atypical mycobacteriosis), duodenal ulcer and peptic ulcer.
To prescribe this antibacterial agent is strictly not recommended in case the patient has an increased sensitivity to clarithromycin, erythromycin or any other macrolides. In addition, the drug "Klabaks" instruction for use does not recommend use in porphyria, hypokalemia, hepatitis, and also in combination with astemizole, cisapride, pimozide or terfenadine. With great care it is necessary to take this medicine in case of hepatic or renal insufficiency. In addition, it is not recommended to prescribe this antibiotic for people younger than six months due to lack of necessary experience in clinical trials.
With regard to possible side effects, the use of this drug may cause the development of thrush, leukopenia, hypoglycemia and cholestasis. There may be diarrhea, nausea, tongue inflammation, dyspepsia, paresthesia, urticaria, headache, insomnia, dizziness, hallucinations, disorientation, ringing in the ears, depersonalization and psychosis.